about
Influence of a Double-Lumen Extension Tube on Drug Delivery: Examples of Isosorbide Dinitrate and DiazepamEffect of insulin infusion line on glycaemic variability in a perioperative high dependency unit (HDU): a prospective randomised controlled trialDynamic Image Analysis To Evaluate Subvisible Particles During Continuous Drug Infusion In a Neonatal Intensive Care Unit.Criteria for choosing an intravenous infusion line intended for multidrug infusion in anaesthesia and intensive care units.Factors Generating Glucose Degradation Products In Sterile Glucose Solutions For Infusion: Statistical Relevance Determination Of Their Impacts.Endothelial Cell Toxicity of Vancomycin Infusion Combined with Other Antibiotics.Influence of vancomycin infusion methods on endothelial cell toxicity.Identification and quantification by 1H nuclear magnetic resonance spectroscopy of seven plasticizers in PVC medical devices.Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol.Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro studyIn vitro assessment of the influence of intravenous extension set materials on insulin aspart drug deliveryDevelopment and Evaluation of a Hybrid Course in Clinical Virology at a Faculty of Pharmacy in Lille, FranceEffect of multi-lumen perfusion line on catheter-related bacteremia in premature infants: study protocol for a cluster-randomized crossover trialAssessment of anti-factor Xa activity of heparin in binary parenteral nutrition admixtures for premature neonates[Clinical pharmacist and medication reconciliation in kidney transplantation]Proposition of a structured list of information items to be transmitted to primary caregivers after in-hospital medication optimization: a qualitative studyCommunity-Acquired Acute Kidney Injury Induced By Drugs In Older Patients: A Multifactorial EventClinical pharmacist and pharmaceutical interventions in HBH unit: a French observational studyEfficiency of four solutions in removing 23 conventional antineoplastic drugs from contaminated surfaces
P50
Q28551877-3284DFF9-18DA-4FF6-A4AA-4D3AC248FABCQ33894671-E7DB3393-1E57-40E6-8AF0-7903370F06CEQ38609383-44DA8751-A62E-4AB5-8EBD-AA71FEFBBBBBQ38874901-03A56F50-484B-4397-82B5-85CD52041ACFQ41696915-91CBDD11-A486-47D8-BC14-F4DEE7EF05CCQ42348993-98217221-6E45-4741-B65C-CDADD8D8BEF8Q43156951-9D754F83-5603-452A-99CE-DAC43766310AQ48238834-2FC6AD55-7B5E-450E-B9ED-9979A84F1880Q55023288-797247CC-4DBA-4D56-B982-A9083DAAE813Q57280751-FBD7D636-5405-46CD-8BB9-649B8C498DADQ58775278-4768524F-B56C-4A4B-B6F3-90F755367D36Q64055824-7C6496F6-1414-45D8-B816-BD65FF935317Q64237392-84B2151F-18A5-427B-9526-EBAE8F79725EQ87096225-55C494DA-9FD2-4586-8FFA-443EB8252846Q87869117-F30C1654-8E4C-4BE1-B789-5931EAD04250Q91577698-2DF72311-2F4F-45A5-B9AB-3B9E3956A08EQ91866023-51D9CD80-9811-4EE2-8ABF-4D5AA2D5DBA1Q92885699-ED0BCFA8-6565-42B9-B05F-A9793B8AA899Q96617224-54F9890D-53F8-4B82-8ECB-69A045C1E8A3
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-8267-5594
@en
name
Bertrand Décaudin
@ast
Bertrand Décaudin
@en
Bertrand Décaudin
@nl
type
label
Bertrand Décaudin
@ast
Bertrand Décaudin
@en
Bertrand Décaudin
@nl
prefLabel
Bertrand Décaudin
@ast
Bertrand Décaudin
@en
Bertrand Décaudin
@nl
P106
P31
P496
0000-0001-8267-5594